UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013

PloS one, 2017-08, Vol.12 (8), p.e0182750-e0182750

2017

Volltextzugriff (PDF)

Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042

Journal of clinical oncology, 2014-02, Vol.32 (5), p.402-408

2014

Volltextzugriff (PDF)

Evaluation of treatments for HIV-associated Kaposi sarcoma in Africa

Infectious agents and cancer, 2021-04, Vol.16 (1), p.25-25, Article 25

2021

Volltextzugriff (PDF)

Kaposi sarcoma

Nature reviews. Disease primers, 2019-01, Vol.5 (1), p.9-9, Article 9

2019

Volltextzugriff (PDF)

Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma

Clinical cancer research, 2008-12, Vol.14 (24), p.8302-8307

2008

Volltextzugriff (PDF)

Randomized Phase II Trial of Matrix Metalloproteinase Inhibitor COL-3 in AIDS-Related Kaposi's Sarcoma: An AIDS Malignancy Consortium Study

Journal of clinical oncology, 2006-03, Vol.24 (9), p.1389-1394

2006

Volltextzugriff (PDF)

Selective CD4+ Lymphopenia in Melanoma Patients Treated With Temozolomide: A Toxicity With Therapeutic Implications

Journal of clinical oncology, 2004-02, Vol.22 (4), p.610-616

2004

Volltextzugriff (PDF)

Use of liposomal anthracyclines in Kaposi’s sarcoma

Seminars in oncology, 2004-12, Vol.31 (6 Suppl 13), p.36-52

2004

Volltextzugriff (PDF)

Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma

Journal of acquired immune deficiency syndromes (1999), 2011-01, Vol.56 (1), p.64-68

2011

Volltextzugriff (PDF)

Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers

JCO global oncology, 2020-11, Vol.6 (6), p.1134-1146

2020

Volltextzugriff (PDF)

Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study

JCO global oncology, 2020-11, Vol.6 (6), p.1034-1040, Article 1034

2020

Volltextzugriff (PDF)

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3351-3356

2003

Volltextzugriff (PDF)

Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities

Current opinion in oncology, 2011-09, Vol.23 (5), p.463-468

Krown, Susan E

2011

Volltextzugriff (PDF)

Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan Africa

International journal of radiation oncology, biology, physics, 2023-06, Vol.116 (2), p.439-447, Article 439

2023

Volltextzugriff (PDF)

Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortium

Gynecologic oncology, 2019-04, Vol.153 (1), p.20-25

2019

Volltextzugriff (PDF)

Consistent Antibody Response against Ganglioside GD2 Induced in Patients with Melanoma by a GD2 Lactone-Keyhole Limpet Hemocyanin Conjugate Vaccine plus Immunological Adjuvant QS-21

Clinical cancer research, 2003-11, Vol.9 (14), p.5214-5220

2003

Volltextzugriff (PDF)

Molecular and Clinical Assessment in the Treatment of AIDS Kaposi Sarcoma with Valproic Acid

Clinical infectious diseases, 2009-12, Vol.49 (12), p.1946-1946

2009

Volltextzugriff (PDF)

Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma

Journal of clinical oncology, 2004-02, Vol.22 (3), p.399-402

Krown, Susan E

2004

Volltextzugriff (PDF)

Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings

Journal of acquired immune deficiency syndromes (1999), 2023-10, Vol.94 (2), p.165-173

2023

Volltextzugriff (PDF)

Mortality and Associated Risk Factors Among People Living With HIV With Kaposi Sarcoma: A5263/AMC066 and A5264/AMC067

Journal of acquired immune deficiency syndromes (1999), 2024-11, Vol.97 (3), p.216-225

2024

Volltextzugriff (PDF)

Effects of Chemotherapy in AIDS-Associated Non-Hodgkin's Lymphoma on Kaposi's Sarcoma Herpesvirus DNA in Blood

Journal of clinical oncology, 2009-05, Vol.27 (15), p.2496-2502

2009

Volltextzugriff (PDF)

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy

Journal of cancer epidemiology, 2016-01, Vol.2016, p.2138259-9

2016

Volltextzugriff (PDF)

Randomized Trial of Paclitaxel Versus Pegylated Liposomal Doxorubicin for Advanced Human Immunodeficiency Virus-Associated Kaposi Sarcoma: Evidence of Symptom Palliation From Chemotherapy

Cancer, 2010-08, Vol.116 (16), p.3969-3977

2010

Volltextzugriff (PDF)

Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy

Journal of acquired immune deficiency syndromes (1999), 2020-08, Vol.84 (4), p.422-429

2020

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(150)
Buchkapitel
(1)

Sprache

Englisch
(151)

Erscheinungsjahr

n.n

Thema

Humans
(105)
Science & Technology
(101)
Life Sciences & Biomedicine
(97)
Male
(56)
Adult
(52)
Oncology
(52)
Biological And Medical Sciences
(50)
Medical Sciences
(49)
Middle Aged
(47)
Female
(44)
Aids/hiv
(38)
Sarcoma, Kaposi - Drug Therapy
(30)
Immunology
(29)
Aged
(25)
Acquired Immunodeficiency Syndrome - Complications
(24)
Infectious Diseases
(24)
Tumors
(22)
Human Immunodeficiency Virus
(19)
Aids
(18)
Hiv
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013

Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042

Evaluation of treatments for HIV-associated Kaposi sarcoma in Africa

Kaposi sarcoma

Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma

Randomized Phase II Trial of Matrix Metalloproteinase Inhibitor COL-3 in AIDS-Related Kaposi's Sarcoma: An AIDS Malignancy Consortium Study

Selective CD4+ Lymphopenia in Melanoma Patients Treated With Temozolomide: A Toxicity With Therapeutic Implications

Use of liposomal anthracyclines in Kaposi’s sarcoma

Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma

Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers

Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities

Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan Africa

Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortium

Consistent Antibody Response against Ganglioside GD2 Induced in Patients with Melanoma by a GD2 Lactone-Keyhole Limpet Hemocyanin Conjugate Vaccine plus Immunological Adjuvant QS-21

Molecular and Clinical Assessment in the Treatment of AIDS Kaposi Sarcoma with Valproic Acid

Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma

Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings

Mortality and Associated Risk Factors Among People Living With HIV With Kaposi Sarcoma: A5263/AMC066 and A5264/AMC067

Effects of Chemotherapy in AIDS-Associated Non-Hodgkin's Lymphoma on Kaposi's Sarcoma Herpesvirus DNA in Blood

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy

As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial

Randomized Trial of Paclitaxel Versus Pegylated Liposomal Doxorubicin for Advanced Human Immunodeficiency Virus-Associated Kaposi Sarcoma: Evidence of Symptom Palliation From Chemotherapy

Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy

Suchergebnisse filtern